Trials / Conditions / Therapy-Related Myelodysplastic Syndrome

Therapy-Related Myelodysplastic Syndrome

14 registered clinical trials studyying Therapy-Related Myelodysplastic Syndrome — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Venetoclax Basket Trial for High Risk Hematologic Malignancies NCT05292664	Andrew E. Place, MD	Phase 1
Active Not Recruiting	Venetoclax and Azacitidine for Treatment of Therapy Related or Secondary Myelodysplastic Syndrome NCT05379166	Uma Borate	Phase 2
Active Not Recruiting	Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic NCT05316701	Orca Biosystems, Inc.	Phase 3
Terminated	Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malig NCT03272633	Rutgers, The State University of New Jersey	EARLY_Phase 1
Active Not Recruiting	Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or C NCT04550442	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Terminated	Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome NCT04160052	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Completed	Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome NCT03359460	University of California, Davis	Phase 1
Completed	Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients W NCT03096782	M.D. Anderson Cancer Center	Phase 2
Completed	Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies NCT02960646	M.D. Anderson Cancer Center	Phase 1
Recruiting	Personalized NK Cell Therapy in CBT NCT02727803	M.D. Anderson Cancer Center	Phase 2
Completed	Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia NCT02658487	Vanderbilt-Ingram Cancer Center	Phase 2
Active Not Recruiting	Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Le NCT01885689	City of Hope Medical Center	Phase 2
Completed	Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignan NCT01823198	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Unknown	NK Cells in Cord Blood Transplantation NCT01619761	M.D. Anderson Cancer Center	Phase 1